S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)

Medtronic - MDT Stock Forecast, Price & News

$86.58
+1.34 (+1.57%)
(As of 02/7/2023 04:35 PM ET)
Add
Compare
Today's Range
$85.10
$86.93
50-Day Range
$76.30
$87.58
52-Week Range
$75.76
$114.31
Volume
5.13 million shs
Average Volume
6.80 million shs
Market Capitalization
$115.17 billion
P/E Ratio
26.89
Dividend Yield
3.12%
Price Target
$94.25

Medtronic MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
8.9% Upside
$94.25 Price Target
Short Interest
Healthy
0.89% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.84
Upright™ Environmental Score
News Sentiment
0.31mentions of Medtronic in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$1.34 M Sold Last Quarter
Proj. Earnings Growth
3.42%
From $5.26 to $5.44 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Medical Sector

20th out of 1,029 stocks

Electromedical Equipment Industry

1st out of 23 stocks

MDT stock logo

About Medtronic (NYSE:MDT) Stock

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Stock News Headlines

Is Medtronic Stock Ready to Revive?
The world’s largest medical device maker Medtronic PLC (NYSE: MDT) stock has fallen since April 2022. However, shares may have bottomed out.
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
2 Beaten-Down Stocks With Stable Dividends to Buy In 2023
Medtronic (MDT) Stock Moves -0.55%: What You Should Know
3 Ways To Shape Equitable Outcomes
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Why Supplier Diversity Matters
3 Stocks to Buy Before the Bull Market
List of AI Healthcare Stocks
Better Buy: InMode or Medtronic?
Medtronic: Destruction Is Nearly Over
Estimating The Intrinsic Value Of Medtronic plc (NYSE:MDT)
See More Headlines
Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Company Calendar

Last Earnings
11/22/2022
Ex-Dividend for 1/13 Dividend
12/20/2022
Dividend Payable
1/13/2023
Today
2/07/2023
Next Earnings (Confirmed)
2/21/2023
Fiscal Year End
4/30/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
58505510
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Forecast
$94.25
High Stock Price Forecast
$135.00
Low Stock Price Forecast
$77.00
Forecasted Upside/Downside
+8.9%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
20 Analysts

Profitability

Net Income
$5.04 billion
Pretax Margin
18.27%

Debt

Sales & Book Value

Annual Sales
$31.69 billion
Cash Flow
$7.57 per share
Book Value
$39.30 per share

Miscellaneous

Outstanding Shares
1,330,180,000
Free Float
1,326,322,000
Market Cap
$115.17 billion
Optionable
Optionable
Beta
0.72

Social Links


Key Executives

  • Geoffrey Straub Martha
    Chairman & Chief Executive Officer
  • Megan Fulton Riddle
    Vice President
  • Gregory L. Smith
    Executive VP-Global Operations & Supply Chain
  • Karen L. ParkhillKaren L. Parkhill
    Chief Financial Officer & Executive Vice President
  • Laura Mauri
    CSO, Chief Medical & Regulatory Officer, Senior VP













MDT Stock - Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 14 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings
or view top-rated stocks.

What is Medtronic's stock price forecast for 2023?

20 brokerages have issued 1-year target prices for Medtronic's stock. Their MDT share price forecasts range from $77.00 to $135.00. On average, they anticipate the company's stock price to reach $94.25 in the next twelve months. This suggests a possible upside of 10.6% from the stock's current price.
View analysts price targets for MDT
or view top-rated stocks among Wall Street analysts.

How have MDT shares performed in 2023?

Medtronic's stock was trading at $77.72 at the start of the year. Since then, MDT shares have increased by 9.7% and is now trading at $85.24.
View the best growth stocks for 2023 here
.

When is Medtronic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our MDT earnings forecast
.

How can I listen to Medtronic's earnings call?

Medtronic will be holding an earnings conference call on Tuesday, February 21st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) posted its earnings results on Tuesday, November, 22nd. The medical technology company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The medical technology company had revenue of $7.59 billion for the quarter, compared to analysts' expectations of $7.70 billion. Medtronic had a trailing twelve-month return on equity of 13.52% and a net margin of 14.03%. The business's quarterly revenue was down 3.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.32 EPS.
Read the conference call transcript
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Thursday, December 8th. Investors of record on Wednesday, December 21st will be given a dividend of $0.68 per share on Friday, January 13th. This represents a $2.72 annualized dividend and a yield of 3.19%. The ex-dividend date is Tuesday, December 20th.
Read our dividend analysis for MDT
.

Is Medtronic a good dividend stock?

Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 3.12%. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 84.47%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 50.00% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic issued an update on its FY 2023 earnings guidance on Thursday, December, 22nd. The company provided EPS guidance of $5.25-$5.30 for the period, compared to the consensus earnings per share estimate of $5.53. The company issued revenue guidance of -.

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by many different institutional and retail investors. Top institutional shareholders include Mitsubishi UFJ Kokusai Asset Management Co. Ltd. (0.29%), Sumitomo Mitsui Trust Holdings Inc. (0.28%), Fisher Asset Management LLC (0.25%), Envestnet Asset Management Inc. (0.24%), New York State Common Retirement Fund (0.22%) and Bank of Montreal Can (0.20%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Plc Medtronic, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends
.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $85.24.

How much money does Medtronic make?

Medtronic (NYSE:MDT) has a market capitalization of $113.38 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.22 on an earnings per share basis.

How many employees does Medtronic have?

The company employs 95,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.

This page (NYSE:MDT) was last updated on 2/7/2023 by MarketBeat.com Staff